BioMarin Pharmaceutical (BMRN) Insider Trading & Ownership $62.56 +0.59 (+0.95%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.85%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$17.86 M Get BMRN Insider Trade Alerts Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMRN Insider Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. BioMarin Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/12/2024Charles Greg GuyerEVPSell5,278$66.37$350,300.86 5/30/2024Brian MuellerCFOSell5,000$75.19$375,950.00 5/28/2024George Eric DavisEVPSell40,850$74.51$3,043,733.50 5/9/2024Jean Jacques BienaimeDirectorSell20,000$81.62$1,632,400.00 5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.50 4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.00 3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.68 3/5/2024Henry J FuchsInsiderSell35,341$85.18$3,010,346.38 3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00 3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.00 2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00 2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00 1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00 12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00 12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.20 (Data available from 1/1/2013 forward) BMRN Insider Trading Activity - Frequently Asked Questions Who is on BioMarin Pharmaceutical's Insider Roster? The list of insiders at BioMarin Pharmaceutical includes Brian Mueller, Charles Greg Guyer, Dennis Slamon, Erin Burkhart, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Mark J Alles, Richard A Meier, and V Bryan Lawlis. Learn more on insiders at BMRN. What percentage of BioMarin Pharmaceutical stock is owned by insiders? 1.85% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings. Which BioMarin Pharmaceutical insiders have been selling company stock? The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($2,193,623.17), Charles Greg Guyer ($350,300.86), Erin Burkhart ($205,740.00), George Eric Davis ($7,669,671.88), Henry J Fuchs ($4,095,506.38), Jean Jacques Bienaime ($18,949,470.00), Jeffrey Robert Ajer ($6,467,580.00), and V Bryan Lawlis ($825,265.00). How much insider selling is happening at BioMarin Pharmaceutical? Insiders have sold a total of 433,351 BioMarin Pharmaceutical shares in the last 24 months for a total of $40,757,157.29 sold. BioMarin Pharmaceutical Key ExecutivesMr. Alexander Hardy (Age 55)President, CEO & Director Compensation: $1.72MMr. Brian R. Mueller (Age 50)CFO & Executive VP Compensation: $1.07M1 recent tradesDr. C. Greg Guyer Ph.D. (Age 62)Executive VP & Chief Technical Officer Compensation: $1.11MMr. Jeffrey Robert Ajer (Age 62)Executive VP & Chief Commercial Officer Compensation: $1.1MDr. Henry J. Fuchs M.D. (Age 66)Ph.D., President of Worldwide Research & Development Compensation: $1.41MMs. Erin Burkhart (Age 45)Group VP & Chief Accounting Officer Dr. Kevin Eggan Ph.D.Chief Scientific Officer & Senior VP of Research and Early DevelopmentTraci McCartyGroup Vice President of Investor RelationsMr. George Eric Davis (Age 53)Executive VP, Chief Legal Officer, General Counsel & Secretary Compensation: $1.23M1 recent tradesMs. Humaira SerajuddinSenior VP & Chief Marketing Officer More Insider Trading Tools from MarketBeat Related Companies SRPT Insider Buying TEVA Insider Buying VYGR Insider Buying ALNY Insider Buying BIIB Insider Buying UTHR Insider Buying INCY Insider Buying NBIX Insider Buying EXEL Insider Buying EXAS Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:BMRN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMRN Stock Alerts